Skip to main content

You must have JavaScript enabled in order to access this part of the site. Please enable JavaScript and then reload this page in order to continue.

Respiratory Syncytial Virus Prophylaxis Season Reopening Across All Regions

Last updated on

The Texas Health and Human Services Commission (HHSC) is aware of a summertime Respiratory Syncytial Virus (RSV) resurgence in multiple regions across the state.

In response to this RSV activity and consultation with medical experts from across the state, HHSC will take necessary action to prevent the further spread of RSV by reopening all regions to monthly administration of palivizumab (Synagis) prophylaxis to eligible members, starting June 1, 2022.

Other news

Members Sought for the Drug Utilization Review Board until June 1, 2022